ORIENTBIO Inc. | Cash Flow
Fiscal year is April-March. All values KRW Millions.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
10,218
1,786
2,516
25,297
16,211
30,174
Depreciation, Depletion & Amortization
4,177
6,230
5,508
6,665
7,296
8,078
Other Funds
18
-
103
1
40
5,918
Funds from Operations
3,244
3,452
2,526
8,766
3,846
16,179
Changes in Working Capital
5,413
1,849
9,850
3,658
1,879
4,639
Net Operating Cash Flow
2,169
1,603
7,324
5,108
1,966
11,540
Capital Expenditures
12,233
7,274
10,357
6,630
3,593
Sale of Fixed Assets & Businesses
115
7,518
99
24,320
1,153
Purchase/Sale of Investments
39
2,701
245
139
10,293
Net Investing Cash Flow
12,638
664
11,013
15,456
25,509
Issuance/Reduction of Debt, Net
52
854
1,067
224
32,854
Net Financing Cash Flow
9,643
819
25,526
223
32,903
Net Change in Cash
826
120
7,190
10,571
5,428
Free Cash Flow
8,262
3,506
15,247
10,391
4,953
Deferred Taxes & Investment Tax Credit
30
38
123
2,024
-
-
Net Assets from Acquisitions
-
1,596
-
-
11,258
Other Sources
325
2,100
1,650
395
2,226
Change in Capital Stock
9,609
35
26,490
-
10
Other Uses
807
4,114
2,160
2,490
3,744
About ORIENTBIO
View Profile
